[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


[Asia Economy Reporter Koo Chae-eun] In the UK, which was the first in the world to start administering Pfizer's novel coronavirus (COVID-19) vaccine, two people showed allergic reactions within a day.


According to multiple foreign media reports on the 9th, those who showed allergic reactions were National Health Service (NHS) staff. It was reported that symptoms of anaphylaxis appeared after receiving the vaccine on the 8th. The NHS and the Medicines and Healthcare products Regulatory Agency (MHRA) have advised that people who have previously experienced allergic reactions to drugs, food, or vaccines should refrain from getting the vaccine for the time being while investigations are ongoing.


Professor Stephen Powis, Medical Director of NHS England, said, "Those with a history of allergic reactions should avoid vaccination. This is a common occurrence with new vaccines and is a precautionary measure."


Meanwhile, Pfizer stated that more than 44,000 people have participated in clinical trials so far, with 42,000 of them having already completed two doses. They emphasized that no serious safety concerns related to the vaccine have been raised during Phase 3 clinical trials.



A Pfizer spokesperson explained, "The MHRA has issued provisional guidelines to be applied while investigations are conducted to fully understand the cause of the allergic reactions," adding, "We plan to support the investigation for this purpose."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing